IgG Fc Fragment as a Scaffold for Development of Targeted Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|17|15|1315-1323

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.17, Iss.15, 2016-12, pp. : 1315-1323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 15, 2016-12 ,pp. : 1333-1347

Bentham Science Publishers

Access to resources Recommend Favorite

Carbamazepine: IgG deficiency in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1017, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

A Critical Evaluation of Tm(FTIR) Measurements of High-Concentration IgG1 Antibody Formulations as a Formulation Development Tool

By Matheus Susanne   Mahler Hanns-Christian   Friess Wolfgang  

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1617-1627

Springer Publishing Company

Access to resources Recommend Favorite

Fractional Carbon Dioxide Laser Treatment to Enhance Skin Permeation of Ascorbic Acid 2-Glucoside with Minimal Skin Disruption

By Hsiao Chien-Yu   Huang Chun-Hsun   Hu Sindy   Ko Yu-Shien   Sung Hsin-Ching   Chen Chih-Chun   Huang Shih-Yi  

Dermatologic Surgery, Vol. 38, Iss. 8, 2012-08 ,pp. : 1284-1293

Elsevier

Access to resources Recommend Favorite

The Application of Phage Display in Allergy Research: Characterization of IgE, Identification of Allergens and Development of Novel Therapeutics

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 225-240

Bentham Science Publishers

Access to resources Recommend Favorite